295 related articles for article (PubMed ID: 24411578)
1. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
[TBL] [Abstract][Full Text] [Related]
2. Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.
Moon CS; Nanji AA; Galor A; McCollister KE; Karp CL
Ophthalmology; 2016 Mar; 123(3):497-504. PubMed ID: 26686965
[TBL] [Abstract][Full Text] [Related]
3. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
4. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
6. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Galor A; Karp CL; Oellers P; Kao AA; Abdelaziz A; Feuer W; Dubovy SR
Ophthalmology; 2012 Oct; 119(10):1974-81. PubMed ID: 22704832
[TBL] [Abstract][Full Text] [Related]
7. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
Shields CL; Kaliki S; Kim HJ; Al-Dahmash S; Shah SU; Lally SE; Shields JA
Cornea; 2013 Mar; 32(3):248-56. PubMed ID: 22580436
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Kim BH; Kim MK; Wee WR; Oh JY
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
[TBL] [Abstract][Full Text] [Related]
9. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
10. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium.
Oellers P; Karp CL; Sheth A; Kao AA; Abdelaziz A; Matthews JL; Dubovy SR; Galor A
Ophthalmology; 2013 Mar; 120(3):445-450. PubMed ID: 23107578
[TBL] [Abstract][Full Text] [Related]
14. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Zaki AA; Farid SF
Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
[TBL] [Abstract][Full Text] [Related]
15. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Karp CL; Moore JK; Rosa RH
Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
17. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
[TBL] [Abstract][Full Text] [Related]
18. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
Holcombe DJ; Lee GA
Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
[TBL] [Abstract][Full Text] [Related]
19. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.
Yousef YA; Finger PT
Ophthalmology; 2012 Feb; 119(2):233-40. PubMed ID: 22189448
[TBL] [Abstract][Full Text] [Related]
20. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]